September 20, 2012

Sanofi and TB Alliance Announce Collaboration to Accelerate New Treatments Against Tuberculosis

- Goal is to select novel clinical development candidates to help stop the global pandemic -

 

Sanofi and TB Alliance Announce Collaboration to Accelerate New Treatments Against Tuberculosis
- Goal is to select novel clinical development candidates to help stop the global pandemic -

Paris, France and New York, New York, September 20, 2012 – Sanofi (EURONEXT: SAN and NYSE: SNY) and the Global Alliance for TB Drug Development (TB Alliance) announced today a new research collaboration agreement to accelerate the discovery and development of novel compounds against tuberculosis (TB), a deadly infectious disease that resulted in almost 1.5 million deaths worldwide1 in 2010.